Company Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Biotechnology & Medical Research

Delayed Nasdaq 04:30:00 2024-03-27 pm EDT 5-day change 1st Jan Change
4.94 USD -1.59% Intraday chart for Champions Oncology, Inc. -10.18% -12.10%

Business Summary

Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a-service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverages the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmacology Services
94.1 %
47 95.4 % 51 94.1 % +8.27%
Other Translational Oncology Solutions
5.7 %
2 4.5 % 3 5.7 % +36.78%
Personalized Oncology Services
0.2 %
0 0.1 % 0 0.2 % +136.73%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
49 100.0 % 54 100.0 % +9.69%

Managers

Managers TitleAgeSince
Chief Executive Officer 58 10-10-25
President - 23-10-16
Chairman 59 10-10-25
Director of Finance/CFO 55 13-05-31
Chief Tech/Sci/R&D Officer - 19-08-31
Chief Operating Officer - 15-02-28
Director/Board Member 71 16-04-10
Public Communications Contact - -
Corporate Officer/Principal - 20-02-29
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Founder 64 07-12-31
Director/Board Member 53 11-06-26
Chairman 59 10-10-25
Director/Board Member 60 13-02-28
Chief Executive Officer 58 10-10-25
Director/Board Member 71 16-04-10
Director/Board Member 53 21-02-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,714,099 10,119,930 ( 73.79 %) 120,333 ( 0.8774 %) 73.79 %

Shareholders

NameEquities%Valuation
Battery Ventures
17.81 %
2,421,673 17.81 % 14 M $
NEA Management Co. LLC
12.61 %
1,713,720 12.61 % 10 M $
West Elk Capital LLC
8.043 %
1,093,387 8.043 % 6 M $
858,878 6.318 % 5 M $
767,043 5.643 % 4 M $
742,445 5.462 % 4 M $
742,161 5.460 % 4 M $
Tocqueville Asset Management LP
5.036 %
684,578 5.036 % 4 M $
198,625 1.461 % 1 M $
Renaissance Technologies LLC
0.9180 %
124,791 0.9180 % 710 061 $

Company contact information

Champions Oncology, Inc.

One University Plaza Suite 307

07601, Hackensack

+201 808 8400

http://www.championsoncology.com
address Champions Oncology, Inc.(CSBR)